Oncology & Cancer
Bevacizumab active in HIV-linked Kaposi's sarcoma
(HealthDay) -- For patients with HIV-associated Kaposi's sarcoma (HIV-KS), bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of Clinical Oncology.
Mar 20, 2012
0
0
